Review article · 19 Apr 2025
Mini reviewPublished 20 Nov 2020
A Note on Pancreatic Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic adenocarcinoma is a lethal condition with aincreasingfrequency, predicted to become the second prominent cause of cancer death in some regions. It frequently presents at an advanced stage, which contributes to poor five-year survival rates of 2%-9%, ranking firmly last amongst all cancer sites in terms of predictive outcomes for patients. Better understanding of the risk factors and symptoms accompanying with this disease is significant to advise both health professionals and the general population of potential preventive and/or early detection measures. The management of pancreatic adenocarcinoma is increasing, with the overview of new surgical approaches and medical treatments such as laparoscopic methods and neo-adjuvant chemoradiotherapy, though this has only led to modest developments in results.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Molecular Endocrinology.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Molecular Endocrinology
- SubjectDiabetes & Endocrinology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Anupama Bulla”

